Find coverage and reimbursement service for transplant patients on Valcyte® (valganciclovir
hydrochloride) and CellCept® (mycophenolate mofetil) with
Genentech® Transplant Access Services (GTAS).
INDICATIONS: Adults Patients: Valcyte®
Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.
Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.
Find coverage and reimbursement service for transplant patients on Valcyte® (valganciclovir
hydrochloride) and CellCept® (mycophenolate mofetil) with
Genentech® Transplant Access Services (GTAS).
INDICATIONS: Adults Patients: Valcyte®
Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.
Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.
Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.
Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.
Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.
Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.
Explore new research in cancer and learn how Genentech is transforming the way cancer is treated with innovative methods that target cancer and advance cancer research.